๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial

โœ Scribed by Rudolph M. Navari; Marie C. Brenner

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
120 KB
Volume
18
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Treatment of anorexia and weight loss wi
Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis
โœ Samya Z. Nasr; Martin E. Hurwitz; Randall W. Brown; Mahmoud Elghoroury; David Ro ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 22 KB ๐Ÿ‘ 2 views

Four patients with severe cystic fibrosis lung disease, anorexia and weight loss, received Megestrol Acetate (MA), as an appetite stimulant. The initial dose was 400-800 mg daily and was continued for 6-15 months. Appetite was improved, with significant weight gain in all patients and an increase in

A randomized trial of megestrol acetate
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer: A study of the Eastern Cooperative Oncology Group (E2185)
โœ Charles D. Cobau; Katrien Declercq; Donna Neuberg; James N. Ingle; Douglass C. T ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 519 KB

## BACKGROUND. Human breast cancer cells in vitro exhibit increased levels of progestin receptors (PgR) after brief exposure to physiologic concentrations of estrogens. Prior clinical studies have positively correlated the responsiveness of metastatic breast cancer to progestin therapy with the le